Skip to Main Content

Paper Details

Use of convalescent plasma in COVID-19 patients with immunosuppression.
Transfusion
59
2021
COVID-19, convalescent plasma, coronavirus 2, hematological malignancies, human, human convalescent plasma, immune-deficient, immune-suppressed, immunosuppression, novel coronavirus disease, patients, severe acute respiratory syndrome
Author NameAffiliation
Jonathon W SenefeldMayo Clinic
Stephen A KlassenMayo Clinic
Chad C WigginsMayo Clinic
Sarah E BakerMayo Clinic
Patrick W JohnsonMayo Clinic
Rickey E CarterMayo Clinic
Liise-Anne PirofskiAlbert Einstein College of Medicine
R. Scott WrightMayo Clinic
DeLisa FairweatherMayo Clinic
Katelyn A BrunoMayo Clinic
Nigel PanethMichigan State University
Nigel PanethMichigan State University
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
Arturo CasadevallJohns Hopkins Bloomberg School of Public Health
Michael J JoynerMayo Clinic
  • 1 - 15

Datasets

Release 1.2